BMY
$51.30
Bristol-Myers Squibb
($.06)
(.12%)
Earnings Details
Quarter December 2018
Thursday, January 24, 2019 6:59:00 AM
Tweet Share Watch
Summary

Bristol-Myers Squibb Beats

Bristol-Myers Squibb (BMY) reported Quarter December 2018 earnings of $0.94 per share on revenue of $6.0 billion. The consensus earnings estimate was $0.85 per share on revenue of $6.0 billion. The Earnings Whisper number was $0.86 per share. Revenue grew 9.6% on a year-over-year basis.

Bristol-Myers Squibb Co is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products.

Results
Reported Earnings
$0.94
Earnings Whisper
$0.86
Consensus Estimate
$0.85
Reported Revenue
$5.97 Bil
Revenue Estimate
$5.98 Bil
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release

Bristol-Myers Squibb Announces Time Change for Q4 Earnings Results Conference Call

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) announced today that its fourth quarter 2018 earnings call has been rescheduled for two hours earlier than previously announced. The new time for the call is 8:30 a.m. ET today. The dial-in information remains the same and is listed below. During the conference call, company executives will review financial information and will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing in the U.S. toll free 800-458-4121 or international 786-789-4772, confirmation code: 9368504. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 11:45 a.m. ET on January 24 through 11:45 a.m. ET on February 7, 2019. The replay will also be available through http://investor.bms.com or by dialing in the U.S. toll free 888-203-1112 or international 719-457-0820, confirmation code: 9368504.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

Bristol-Myers Squibb Company
Media:
Carrie Fernandez, 609-252-5222, carrie.fernandez@bms.com

Investors:
John Elicker, 609-252-4611, john.elicker@bms.com

Tim Power, 609-252-7509, timothy.power@bms.com

Bill Szablewski, 609-252-5894, william.szablewski@bms.com

Source: Bristol-Myers Squibb Company